4AB:FRA
AbbVie Common Stock
€256.30
arrow_upward
+0.20%(+0.50) 1D
ኦክቶ 28, 8:37:28 ጥዋት ጂ ኤም ቲ+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4AB...
Open
€256.30
High
€256.30
Low
€256.30
Mkt. cap
506.08 ቢ
Avg. vol.
86.00
Volume
0.00
52-wk high
€259.60
52-wk low
€167.55
No. of employees
57 ሺ
Open
€256.30
High
€256.30
Low
€256.30
Mkt. cap
506.08 ቢ
Avg. vol.
86.00
Volume
0.00
52-wk high
€259.60
52-wk low
€167.55
No. of employees
57 ሺ
News stories
From web sources and news partners
Traders Union
·
ከ8 ሰዓቶች በፊት
AbbVie stock holds steady as Q3 2026 financial results investor call
Traders Union
·
ከ13 ሰዓቶች በፊት
AbbVie growth drugs support stock buy case as Humira transition eases
CNBC
·
ከ14 ሰዓቶች በፊት
I just bought this pharma stock for its next generation of blockbuster drugs — and its dividend
The Globe and Mail
·
ከ15 ሰዓቶች በፊት
Buy, Hold or Sell ABBV Stock? Key Tips Ahead of Q3 Earnings
Profile
AbbVie Inc., also known as AbbVie, is an American pharmaceutical company headquartered in North Chicago, Illinois. AbbVie produces drugs to treat a wide range of medical issues.
The company is ranked sixth on the list of largest biomedical companies by revenue. It is ranked 77th on the Fortune 500 and 108th on the Forbes Global 2000. The name "AbbVie" is derived from a combination of "Abbott", the name of its former parent company, with "vie", intended as a reference to a Latin root meaning 'life'. Wikipedia
About AbbVie Common Stock
CEORobert A. Michael
Employees57 ሺ
Founded10 ኤፕሪ 2012
HeadquartersNorth Chicago, ኢሊኖይ, ዩናይትድ ስቴትስ
SectorBiotechnology
Websiteabbvie.com